Fundraising Fox
Spherebio
1 known investors
Find your way into Spherebio
Sign up to see every warm intro you have to Spherebio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Spherebio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
SphereBio develops individualized cancer immunotherapies using engineered biological vesicles (OncoSpheres™) that capture a patient's own tumor antigens and deliver them into immune cells to train the immune system against cancer. The company combines biotechnology, synthetic virology, and AI to create individualized cancer vaccines manufactured without sequencing in under seven days.
Founders & leadership
JP
Julieta PortaCOO & Co-founderJulieta Porta is COO and co-founder of SphereBio Technologies, where she leads operations, strategy, and finance alongside co-founders Guido Molina (Ph.D. in virology and immunology) and Martín Guerrero (M.D. and Ph.D. in machine learning applied to cancer genomics).
GM
Guido MolinaCo-founder (Molecular Biologist)Guido Molina holds a PhD in Molecular Biology from the University of Buenos Aires and has over a decade of research experience in immunology and virology at institutions including CONICET, INTA, and ICGEB. He is Chief Scientific Officer at SphereBio, where he leads technology development for individualized cancer immunotherapies.
MG
Martin GuerreroCo-founder (Physician & Bioinformatician)Martin Guerrero is a physician and bioinformatician who serves as co-founder and CEO of SphereBio, which develops individualized cancer vaccines using engineered biological vesicles to train immune systems against cancer. He brings over a decade of experience in healthcare and translational science, with expertise in oncology, immunotherapy, and intracellular delivery mechanisms.
Investors · 1
Frequently asked questions
- What does Spherebio do?
- SphereBio develops individualized cancer immunotherapies using engineered biological vesicles (OncoSpheres™) that capture a patient's own tumor antigens and deliver them into immune cells to train the immune system against cancer. The company combines biotechnology, synthetic virology, and AI to create individualized cancer vaccines manufactured without sequencing in under seven days.
- Who founded Spherebio?
- Spherebio was founded by Julieta Porta, Guido Molina, Martin Guerrero.
- Who are Spherebio's investors?
- Spherebio's investors include GRIDX.